Role of stromal fibroblasts in cancer: Promoting or impeding?

Tumor Biology

Volumn 30, Issue 3, 2009, Pages 109-120

  Angeli, Flora ^a   Koumakis, George ^a   Chen, Min Che ^b   Kumar, Shant ^b   Delinassios, John G ^a  

^a International Institute of Anticancer Research   (Greece)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cytokines; Fibroblasts; Immunomodulation; Myofibroblasts; Platelet derived growth factor; Stroma; Transforming growth factor ; Tumour; Vascular endothelial growth factor

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTEGRIN; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; FIBROBLAST; GRAFT REJECTION; HUMAN; INFLAMMATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROMA CELL; TISSUE INJURY; TUMOR CELL; TUMOR GROWTH;

EID: 65549114235     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218708     Document Type: Review

References (108)

1. Chu CA, Kimmelman AC, Hezel AF, DePinho RA: Stromal biology of pancreatic cancer. J Cell Biochem 2007;101:887-907.
2. Bhowmick NA, Moses HL: Tumor-stroma interactions. Curr Opin Genet Dev 2005;15:97-101.
3. Mueller MM, Fusenig NE: Friends or foes: bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4:839-849.
4. Baglole CJ, Ray DM, Bernstein SH, Feldon SE, Smith TJ, Sime PJ, Phipps RP: More than structural cells, fibroblasts create and orchestrate the tumour microenvironment. Immun Invest 2006;35:297-325.
5. Brown KM, Quiros RM, Amatangelo MD, Watson JC, Hoffman JP, Cukierman E: Fibroblast-derived 3D matrices characterize human pancreatic cancer stromagenesis. Ann Surg Oncol 2006;13(suppl):74-75.
6. Tremblay G: Stromal aspects of breast carcinoma. Exp Mol Pathology 1979;31:248-260.
7. Ronnov-Jessen L, Petersen OW, Bissell MJ: Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996;76:69-125. (Pubitemid 26048279)
8. Joachim HL: The stromal reaction of tumours and expression of immune surveillance. J Nat Cancer Inst 1976;57:465-475.
9. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000;100:57-70.
10. Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003;3:422-433.
11. Kalluri R, Zeisbeirg M: Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
12. Virchow R: Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre. Berlin, Hirschwald, 1858.
13. Tarin D, Croft CB: Ultrastructural features of wound healing in mouse skin. J Anat 1969;105:189-190.
14. Bancroft JD, Gamble M: Theory and Practice of Histological Techniques, ed 6. Amsterdam, Elsevier, 2007.
15. Mauch C, Kreig T: Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis. Rheum Dis Clin North Am 1990;16:93-107. (Pubitemid 20116147)
16. Tettamanti G, Grimaldi A, Rinaldi L, Arnaboldi F, Congiu T, Valvssori R, de Eguileor M: The multifunctional role of fibroblasts during wound healing in Hirudo medicinalis (Annelida, Hirudinea). Biol Cell 2004;96:443-455.
17. Brown B, Lindberg K, Reing J, Stolz DB, Badylak SF: The basement membrane component of biologic scaffolds derived from extracellular matrix. Tissue Eng 2006;12:519-526. (Pubitemid 43673457)
18. Baker EA, Leaper DJ, Hayter JP, Dickenson AJ: The matrix metalloproteinase system in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 2006;44:482-486. (Pubitemid 44644912)
19. Taniwaki K, Fukamachi H, Komori K, Ohtake Y, Nonaka T, Sakamoto T, Shiomi T, Okada Y, Itoh T, Itohara S, Seiki M, Yana I: Stroma-derived matrix metalloproteinases (MMP-2) promotes membrane type-1-MMP-dependent tumor growth in mice. Cancer Res 2007;67:4309-4311. (Pubitemid 46815079)
20. Roderfeld M, Hemmann S, Roeb E: Mechanisms of fibrolysis in chronic liver injury (with special emphasis on MMPs and TIMPs. Z Gastroenterol 2007;45:25-33.
21. Werner JA, Rathcke IO, Mandic R: The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 2002;19:275-282. (Pubitemid 34606752)
22. Lochter A, Sternlicht MD, Werb Z, Bissel MJ: The significance of matrix metalloproteinases during early stages of tumor progression. Ann NY Acad Sci 1998;857:180-193. (Pubitemid 28526265)
23. Noel A, De Pauw-Gillet MC, Purnell G, Nusgens B, Lapiere CM, Foidart JM: Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by Matrigel and fibroblasts. Br J Cancer 1993;68:909-915. (Pubitemid 23315222)
24. Bauer G: Reactive oxygen and nitrogen species: efficient, selective and interactive signals during intercellular induction of apoptosis. Anticancer Res 2000;20:4115-4140.
25. Delinassios JG, Kottaridis SD and Garas J: Uncontrolled growth of tumour stromal fibroblasts in vitro. Exp Cell Biol 1983;51:201-209.
26. Delinassios JG: Prolonged in vitro maintenance of human diploid fibroblasts on a new tissue-culture medium. Exp Cell Biol 1983;51:315-321.
27. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Genesan S, Glod JW, Banerjee D: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008;68:4331-4339.
28. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3:349-363. (Pubitemid 34619269)
29. Chaponnier C, Desmouliere A, Gabbiani G: Tissue repair, contraction and the myofibroblast. Austin, Landes Bioscience & Springer, 2006 .
30. Azzarone B, Pedulla D, Romanzi CA: Spontaneous transformation of human skin fibroblasts derived from neoplastic patients. Nature 1976;262:74-75.
31. Delinassios JG, Pandis NB, Margaronis M, Kottaridis SD: Double minutes in fibroblast-like cells isolated from human tumors. Experientia 1981;37:569-570. (Pubitemid 11046044)
32. Gabbiani G: The myofibroblast in wound healing and fibrocontructive diseases. J Pathol 2003;200:500-503.
33. Shekhar MPV, Pauley R, Heppner G: Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003;5:130-135.
34. De Wever O, Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol 2003;200:429-447. (Pubitemid 36818244)
35. Schedin P, Elias A: Multistep tumorigenesis and the microenvironment. Breast Cancer Res 2004;6:93-101.
36. van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM: The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 2003;82:539-548.
37. Carmeliet P, Jain RK: Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
38. Neuhaus T, Pabst S, Stier S, Weber AA, Schoror K, Sachinidis A, Vetter H, Ko YD: Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate. Eur J Pharmacol 2004;483:223-227. (Pubitemid 38068403)
39. Folkman J: Is angiogenesis an organizing principle in biology and medicine? J Pediatr Surg 2007;42:1-11.
40. Dvorak HF: Tumors: Wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-1659.
41. Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF: Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res 1999;5:1041-1056. (Pubitemid 29233218)
42. Verona EV, Elkahloun AG, Yang J, Bandyopadhyay A, Yeh IT, Sun LZ: Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res 2007;67:5737-5746. (Pubitemid 46985006)
43. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL: TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004;303:848-851. (Pubitemid 38174665)
44. Bhowmick NA, Neilson EG, Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-337.
45. Westermark B, Heldin CH: Platelet-derived growth factor in autocrine transformation. Cancer Res 1991;51:5087-5092.
46. Bronzert DA, Pantazis P, Antoniades HN, Kasid A, Davidson N, Dickson RB, Lippman ME: Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci USA 1987;84:5763-5767. (Pubitemid 17130415)
47. Peres R, Betsholtz C, Westermark B, Heldin CH: Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res 1987;47:3425-3429. (Pubitemid 17095996)
48. Rozengurt E, Sinnett-Smith J, Taylor-Papadimitriou J: Production of PDGF-like growth factor by breast cancer cell lines. Int J Cancer 1985;36:247-252. (Pubitemid 15243452)
49. Forsberg K, Valyi-Nagy I, Heldin CH, Herlyn M, Westermark B: Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc Natl Acad Sci USA 1993;90:393-397. (Pubitemid 23028868)
50. Skobe M, Fusenig NE: Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc Natl Acad Sci USA 1998;95:1050-1055. (Pubitemid 28124910)
51. Shao ZM, Nguyen M, Barsky SH: Human breast carcinoma desmoplasia is PDGF initiated. Oncogene 2000;19:4337-4345. (Pubitemid 30744363)
52. Ronnov-Jessen L, Petersen OW: Induction of alpha-smooth muscle actin by transforming growth factor-beta1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 1993;68:696-707. (Pubitemid 23202798)
53. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Gramates P, Deuel TF: Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet derived growth factor. Proc Natl Acad Sci USA 1989;86:2229-2233. (Pubitemid 19102483)
54. Sieweke MH, Thompson NL, Sporn MB, Bissell MJ: Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. Science 1990;248:1656-1660. (Pubitemid 20220142)
55. Hagood JS, Prabhakaran P, Kumbla P, Salazar L, Macewen MW, Barker TH, Ortiz LA, Schoeb T, Siegal GP, Alexander CB, Pardo A, Selman M: Loss of fibroblast thy-1 expression correlates with lung fibrogenesis. Am J Pathol 2005;167:365-379. (Pubitemid 43026094)
56. Silzle T, Kreutz M, Dobler MA, Brockhoff G, Knuechel R, Kunz-Schughart LA: Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 2003;33:1311-1320. (Pubitemid 36612030)
57. Lejeune FJ, Ruegg C, Lienard D: Clinical applications of TNF-α in cancer. Current Opin Immunol 1998;10:573-580.
58. Goldberg MT, Han YP, Yan C, Shaw MC, Garner WL: TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication of abnormal wound healing. J Invest Dermatol 2007;127:2645-2655. (Pubitemid 47585056)
59. Getzenberg RH, Pienta KJ, Huang EY, Murphy BC, Coffey DS: Modifications of the intermediate filament and nuclear matrix networks by the extracellular matrix. Biochem Biophys Res Commun 1991;179:340-344.
60. Saito N, Kameoka S: Serum laminin is an independent prognostic factor in colorectal cancer. Int J Colorectal Dis 2005;20:238-244. (Pubitemid 40553002)
61. Bento PM, Freitas RA, Pinto LP, Souza LB: Tensacin and fibronectin in pleomorphic adenoma of the salivary gland. J Appl Oral Sci 2006;14:198-202. (Pubitemid 44285331)
62. Ramos DM, Chen BL, Boylen K, Stern M, Kramer RH, Sheppard D, Nishimura SL, Greenspan D, Zardi L, Pytela R: Stromal fibroblasts influence oral squamous-cell carcinoma cell interactions with tenascin-c. Int J Cancer 1997;72:369-376. (Pubitemid 27314900)
63. Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM: AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 2001;92:641-650. (Pubitemid 32385704)
64. Gulubova MV, Vlaykova TI: Significance of tenascin-C, fibronectin, laminin, collagen IV, alpha5beta1 and alpha9beta1 integrins and fibrotic capsule formation around liver metastases originating from cancers of the digestive tract. Neoplasma 2006;53:372-383.
65. LaPierre DP, Lee DY, Li SZ, Xie YZ, Zhong L, Sheng W, Deng Z, Yang BB: The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res 2007;67:4742-4750. (Pubitemid 46910181)
66. Brakebusch C, Bouvard D, Stanchi F, Sakai T, Fässler R: Integrins in invasive growth. J Clin Invest 2002;109:999-1006.
67. Hart IR: Role of intergrins in tumour invasion and metastasis. Exp Dermatol 2004;13:663-663
68. Gumbiner BM: Regulation of cadherin adhesive activity. J Cell Biol 2000;148:399-403.
69. Omelchenko T, Fetisova E, Ivanova O, Bonder EM, Feder H, Vasiliev JM, Gelfand IM: Contact interactions between epitheliocytes and fibroblasts: Formation of heterotypic cadherin containing adhesion sites is accompanied by local cytoskeletal reorganization. Proc Natl Acad Sci USA 2001;98:8632-8637. (Pubitemid 32678079)
70. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148:779-790. (Pubitemid 30679693)
71. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR: Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 1993;169:245-250. (Pubitemid 23063463)
72. Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A, Gamallo C: Anomalous expression of P-cadherin in breast carcinoma: correlation with E-cadherin expression and pathological features. Am J Pathol 1995;146:605-612.
73. Daniels C, Strickland P, Friedmann Y: Expression and functional role of E- and P-cadherin in mouse mammary ductal morphogenesis and growth. Dev Biol 1995;169:511-519.
74. Heimann R, Lan FS, McBride R, Hellman S: Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res 2000;60:298-304. (Pubitemid 30070755)
75. Kippenberger S, Loitsch S, Thaci D, Muller J, Guschel M, Kaufmann R, Bernd A: Restoration of E-cadherin sensitizes human melanoma cells for apoptosis. Melanoma Res 2006;16:393-403. (Pubitemid 44511219)
76. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR: Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996;135:1643-1654. (Pubitemid 26427658)
77. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ: N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147:631-644.
78. Lo Muzio L, Farina A, Rubini C, Coccia E, Capogreco M, Colella G, Leonardi R, Campisi G, Carinci F: Effect of C-Met expression on survival in head and neck squamous cell carcinoma. Tumor Biol 2006;27:115-121.
79. Brewer DB: The fibroblast. Proc R Soc Med 1967;60:778-7781.
80. Komuro T: Re-evaluation of fibroblasts and fibroblast-like cells. Anat Embryol 1990;182:103-112.
81. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M: Fibroblasts regulate the switch from acute to chronic persistent inflammation. Trends Immunol 2001;22:199-204. (Pubitemid 32673659)
82. Silzle T, Randolph GJ, Kreutz M, Kunz-Schughart LA: The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer 2004;108:173-180. (Pubitemid 37541767)
83. Marinova-Mutafchieva L: Mesenchymal cells expressing bone morphogenetic protein receptors are present in rheumatoid arthritis joint. Arthritis Rheum 2000;43:2046-2055.
84. Zhang Y, Cao HJ, Graf B, Meekins H, Smith TJ, Phipps RP: Cutting Edge: CD40 engagement upregulates cyclooxygenase-2 expression and prostaglandin E2 production in human lung fibroblasts. J Immunol 1998;160:1053-1057. (Pubitemid 28093397)
85. Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, Baldwin AS, Makarov SS: NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 1998;95:13859-13864.
86. de Visser KE, Eichten A, Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006;6:24-37. (Pubitemid 43053650)
87. Delinassios JG: Fibroblasts against cancer cells in vitro. Anticancer Res 1987;7:1005-1010.
88. Delinassios JG: Cytocidal effects of human fibroblasts on HeLa cells in vitro. Biol Cell 1987;59:69-78.
89. Cornil I, Theodorescu D, Man S, Herlyn M, Jambrosic J, Kerbel RS: Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci USA 1991;88:6028-6032. (Pubitemid 21914879)
90. Delinassios JG, Kottaridis SD: Interactions between human fibroblasts and HeLa cells in vitro. Biol Cell 1984;50:9-16. (Pubitemid 14145302)
91. Rubin H: Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype. Proc Natl Acad Sci USA 2008;105:6215-6221.
92. Harisi R, Dudas J, Timar F, Pogany G, Timar J, Kovalszky I, Szendroi M, Jeney A: Invasive growth and topoisomerase-switch induced by tumorous extracellular matrix in osteosarcoma cell culture. Cell Biol Int 2005;11:959-967. (Pubitemid 41654802)
93. Matos AJF, Lopes C, Carvalheira J, Santos M, Rutteman GR, Gartner F: E-cadherin expression in canine malignant mammary tumours: Relationship to other clinicopathological variables. J Comp Pathol 2006;134:182-189.
94. Hughes CC: Endothelial-stromal interactions in angiogenesis. Curr Opin Hematol 2008;15:204-209.
95. Lo Muzio L, Campisi G, Farina A, Rubini C, Pannone G, Serpico R, Laino G, De Lillo A, Carinci F: P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. BMC Cancer 2005;5:63. (Pubitemid 41461068)
96. Fritz G, Kaina B: Rho GTPases: promising cellular targets for novel anticancer drugs. Curr Cancer Drug Targets 2006;6:1-14.
97. Ridley AJ: Rho proteins, PI 3-kinases, and monocyte/macrophage motility. FEBS Letters 2001;498:168-171.
98. DeCosse JJ, Gossens C, Kuzma JF, Unsworth BR: Embryonic inductive tissues that cause histologic differentiation of murine mammary carcinoma in vitro. J Natl Cancer Inst 1975;54:913-922.
99. DeCosse JJ, Gossens CL, Kuzma JF, Unsworth BR: Breast cancer: induction of differentiation by embryonic tissue. Science 1973;181:1057-1058.
100. Cooper M, Pinkus H: Intrauterine transplantation of rat basal cell carcinoma as a model for reconversion of malignant to benign growth. Cancer Res 1977;37:2544-2552. (Pubitemid 8150015)
101. Barker SE, Grosse SM, Siapati EK, Kritz A, Kinnon C, Thrasher AJ, Hart SL: Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12. Br J Cancer 2007;97:210-217. (Pubitemid 47057478)
102. Olumi AF, Grossfeld GD, Hayward SW, Caroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59:5002-5011.
103. Hayward SW, Wang Y, Cao M, Hom YM, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR: Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res 2001;61:8135-8142. (Pubitemid 33091604)
104. Haviv I: Regulation of Leukocyte Infiltration into Ovarian Cancer by Tumour-Stroma Interactions: a Microarray View of Cancer Microenvironment. Medicine and Medical Research, Annual Report, 2006.
105. Radisky ES, Radisky DC: Stromal induction of breast cancer: Inflammation and invasion. Rev Endocr Metab Disord 2007;8:279-287. (Pubitemid 47524870)
106. Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M: Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 2007;13:2082-2090. (Pubitemid 46649876)
107. Papazafiri P, Kletsas D: Developmental and age-related alterations of calcium homeostasis in human fibroblasts. Exp Gerontol 2003;38:307-311. (Pubitemid 36170326)
108. Hewitt RE, Powe DG, Carter I, Turner D: Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer 1993;53:62-69.